Results 131 to 140 of about 4,770 (180)

CFTR rescue in W1282X cystic fibrosis patient-derived intestinal organoids (PDIOs) mediated by translational readthrough-inducing drugs (TRIDs). [PDF]

Genet Med Open
Perriera R, Ramalho AS, Vermeulen F, Vitale E, Pibiri I, Pace A, Lentini L.   +6 more
europepmc   +1 more source

Cutaneous and Ocular Rosacea Associated with Elexacaftor, Tezacaftor and Ivacaftor, A Treatment for Cystic Fibrosis: A Case Report. [PDF]

J Pediatr Clin Pract
Piednoir A, Troussier F, Descamps M, Lagarce L, Martin L.   +4 more
europepmc   +1 more source

Utilisation of CFTR orthologues to evaluate new therapies for cystic fibrosis [PDF]

, 2022
Ng , Demi
core  

UAB clinical trials pave way to new cystic fibrosis drug [PDF]

, 2017
Staff,
core   +1 more source

Beyond BMI: Nutritional Recovery and Functional Implications of CFTR Modulators in Cystic Fibrosis. [PDF]

Biology (Basel)
Linguiti G, Granberg V, Leonetti G, Lassandro G, Lassandro M, Delvecchio M, Giordano P.   +6 more
europepmc   +1 more source

Elexacaftor-tezacaftor-ivacaftor enhances first-phase insulin secretion and improves glucose control in cystic fibrosis. [PDF]

Endocr Connect
Edlund A, Lindberg U, Fagher K, Påhlman LI.   +3 more
europepmc   +1 more source

Synthetic strategies and therapeutic insights into FDA-approved indole-containing drugs. [PDF]

J Enzyme Inhib Med Chem
Yang T, Zhang Y, Liu P, Qi P, Li X, Zhi W, Zhao L.   +6 more
europepmc   +1 more source

Home sputum collection for <i>Aspergillus fumigatus</i> detection in adults with cystic fibrosis. [PDF]

ERJ Open Res
Hong G, Walsh J, Koshy A, Hsu JY, O'Dea AL, Vesely EM, Memon W, Dezube RH, Goss CH, Goss LB, Greene A, Gross JE, Wilson A, Nichols DP, Zhang SX, Cramer RA.   +15 more
europepmc   +1 more source